Oral roflumilast

DRUG3 trials

Sponsors

The University of Hong Kong, Ahmed Ibrahim, Nora Mohamed Abdelrazik

Conditions

Atopic DermatitisNon-cystic Fibrosis BronchiectasisPsoriasis (PsO)

Phase 2

Roflumilast in Non-CF Bronchiectasis Study

CompletedNCT03428334

The University of Hong KongNon-cystic Fibrosis Bronchiectasis

Start: 2018-05-10End: 2019-08-31Updated: 2019-10-01

A Pilot Study to Assess How Safe and Effective Oral Roflumilast is for Treating Moderate to Severe Psoriasis in Adults

RecruitingNCT07233291

Ahmed IbrahimPsoriasis (PsO)

Start: 2025-08-20End: 2026-02-28Target: 36Updated: 2025-12-02

Evaluation of Efficacy and Safety of Oral Roflumilast for Treatment of Moderate to Severe Atopic Dermatitis in Patients Aged 12 Years and Older: A Pilot Study

RecruitingNCT07297602

Nora Mohamed AbdelrazikAtopic Dermatitis

Start: 2025-11-20End: 2026-05-20Target: 36Updated: 2025-12-30